Completed OBSERVATIONAL NCT05191927

A Nomogram Model to Predict Central Lymphnode Metastasis in Thyroid Papillary Carcinoma

A Nomogram Model to Predict Central Lymphnode Metastasis in Thyroid Papillary Carcinoma Suitable for Primary Hospitals

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Interventions male

Updated 3 times since 2022 Last updated: Dec 29, 2021 Started: Jan 1, 2020 Primary completion: Jan 1, 2021 Completion: Aug 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Thyroid Papillary Carcinoma, this trial is completed. The trial is conducted by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University and has accumulated 3 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Feb 2022 — Jul 2024 [monthly]

Completed

First recorded

Jan 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
The First Affiliated Hospital of Zhengzhou University

Data source: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China